Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (285)

SortShow
Name Institution Why
Jorge Castillo, M.D.Dana-Farber Cancer Institute Why?
Steven P. Treon, M.D., Ph.D.Dana-Farber Cancer Institute Why?
Judith Ann Ferry, M.D.Massachusetts General Hospital Why?
Mikolaj Slabicki, Ph.D.Harvard Medical School Why?
Kipp Andrew Weiskopf, M.D.Dana-Farber Cancer Institute Why?
Michael Levy, Ph.D., M.D.Massachusetts General Hospital Why?
Richard N Pierson, M.D.Massachusetts General Hospital Why?
Leonardo Riella, Ph.D., M.D.Brigham and Women's Hospital Why?
Arnold Stephen Freedman, M.D.Dana-Farber Cancer Institute Why?
Gilles A. Benichou, D.Sc., Ph.D.Massachusetts General Hospital Why?
Veerle I.j. Bossuyt, M.D.Massachusetts General Hospital Why?
E. Antonio Chiocca, M.D.,Ph.D.Brigham and Women's Hospital Why?
Robert Paul Hasserjian, M.D.Massachusetts General Hospital Why?
Clifton Craig Mo, M.D.Dana-Farber Cancer Institute Why?
Aliyah Sohani, M.D.Massachusetts General Hospital Why?
Per Page    Page  of 19last Nextnext
Prev
Search Criteria
  • Antigens CD20
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.